Appili Therapeutics Inc.
APLIF
$0.01
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -718.10K | -903.20K | 158.90K | -374.60K | -545.10K |
| Total Depreciation and Amortization | 2.40K | 2.60K | 2.20K | 2.90K | 2.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.00K | 124.50K | 699.40K | 650.90K | 313.50K |
| Change in Net Operating Assets | 237.40K | 771.40K | -139.90K | -595.20K | 529.40K |
| Cash from Operations | -551.30K | -4.60K | 720.60K | -316.00K | 299.90K |
| Capital Expenditure | -- | -- | 0.00 | -500.00 | -1.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -500.00 | -1.20K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -30.10K | -29.30K | -44.90K | -27.60K | -26.60K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -47.30K | -13.00K | -16.40K | -13.00K | -16.30K |
| Cash from Financing | -56.20K | -30.60K | -42.60K | -29.00K | -31.50K |
| Foreign Exchange rate Adjustments | 43.90K | -39.40K | 48.10K | 3.30K | -300.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -563.70K | -74.60K | 726.10K | -342.20K | 266.80K |